• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ardelyx, Inc. - Common Stock (NQ:ARDX)

    3.270 +0.010 (+0.31%)
    Delayed Quote Updated: 1:33 PM EDT, Oct 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Ardelyx, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    21 22 Next >
    News headline image
    ARDX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ardelyx (NASDAQ: ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Important Notice to Long-Term Shareholders of Anavex Life Sciences Corp. (NASDAQ: AVXL); Ardelyx, Inc. (NASDAQ: ARDX); Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI): Grabar Law Office is Investigating
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Ardelyx to Present New Data on Hyperphosphatemia Management at ASN Kidney Week 2026
    Presentations include real-world XPHOZAH® (tenapanor) data and new insights into hyperphosphatemia management and outcomes 
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Robbins LLP Urges ARDX Stockholders Who Lost Money Investing in Ardelyx, Inc. to Contact the Firm for Information About Leading the Class Action
    From Robbins LLP
    Via Business Wire
    News headline image
    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    ARDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Ardelyx, Inc. Securities Lawsuit - Contact Levi & Korsinsky
    From Levi &amp; Korsinsky, LLP
    Via ACCESS Newswire
    News headline image
    ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Encourages Ardelyx, Inc. (NASDAQ: ARDX) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 16, 2026
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Robbins LLP is Investigating Allegations that Ardelyx, Inc. Misled Investors Regarding the True State of the Company's Commercial Performance and Growth Prospects for its Two Core Drug Products
    San Diego, California--(Newsfile Corp. - September 30, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class... 
    Via Newsfile
    Topics Lawsuit
    News headline image
    Kaplan Fox Encourages Investors of Ardelyx, Inc. (NASDAQ: ARDX) to Contact the Firm Before Lead Plaintiff Deadline on November 16, 2026
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards
    Recognition includes Life Sciences Manufacturer CEO of the Year, Podcast Initiative, and Marketing Team of the Year 
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Kaplan Fox Reminds Investors of Ardelyx, Inc. (NASDAQ: ARDX) to a Securities Class Action Deadline - Contact the Firm Before November 16, 2026
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Kaplan Fox Encourages Investors of Ardelyx, Inc. (NASDAQ: ARDX) to Contact the Firm to Learn About Their Legal Rights
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    Rosen Law Firm Urges Ardelyx, Inc. (NASDAQ: ARDX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire
    News headline image
    Ardelyx, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ARDX
    From DJS Law Group
    Via Business Wire
    News headline image
    Ardelyx Targets $500M Revenue This Year, Profitability by 2027 ↗
    Ardelyx (NASDAQ:ARDX) expects to generate close to $500 million in revenue this year and reach profitability in 2027, supported by continued growth of its IBS-C treatment IBSRELA and hyperphosphatemia... 
    Via MarketBeat
    News headline image
    ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via Business Wire
    News headline image
    ARDX SHAREHOLDER ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Ardelyx (NASDAQ: ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    ARDX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ardelyx (NASDAQ: ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Investor Alert: Robbins LLP Informs Investors of the Ardelyx, Inc. Class Action Lawsuit
    From Robbins LLP
    Via Business Wire
    News headline image
    ARDX INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Ardelyx, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm
    From Holzer & Holzer
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    21 22 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.